Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities.

Nicolette Stogios,Margaret K Hahn,Yona Lunsky,Pushpal Desarkar,Sri Mahavir Agarwal

Journal of psychiatry & neuroscience : JPN（2023）

引用 0|浏览3

暂无评分

摘要

Individuals with intellectual and developmental disabilities are additionally burdened by an increased risk of metabolic comorbidities.[1][1]–[3][2] A contributing factor to this risk is the high rate of antipsychotic use in this population; these psychotropic medications are highly associated

查看译文

关键词

metabolic disturbances,developmental disabilities,antipsychotic-induced

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要